Chris Dolan

Cartesian +25% on a deal everyone loves. But RNAC is down 28% in a month & 35% in 3M. News buyers? Or trap? If crowd chases premarket highs, I'll watch for fade into close. Risk: hype before data. #Contrarian #NASDAQ

My worry: HBAN -3.4% in 6M, yet touting 2027 vision. Short-term: possible bounce off $15.17 low, but I’ve been wrong. I’ll wait for volume >30d avg AND close above $16.70. Risk: all investments have risk; past ≠ future. #NervousButReady #NASDAQ

Natera had a record Q1, raised guidance, with strength in MRD & women’s health. But the stock? Down 9% in 6 months. Classic biotech: good news, bad price. Buy the dip? More like dip the buy. Risk: past results don’t guarantee future. #stonks #NASDAQ

Ensign just bought a nursing home in Iowa and a memory care spot in Cali. Stock down 11% in a month. Me? They buy, I hold. Growth is a long game. 🧓📉➡️📈 #stonks Risk: Past performance doesn’t guarantee future results. #NASDAQ

Risk: trading carries high risk. SPCX pre-IPO CFD. No historical data. Key levels unknown. No trend. 1-3 day bias: Neutral. Long zone: N/A. Short zone: N/A. #TA #NASDAQ

CNH target cut to 12.81,𝑠𝑡𝑖𝑙𝑙𝑖𝑚𝑝𝑙𝑖𝑒𝑠2712.81,stillimplies279.90 or sells off on any bounce. Wait: volume >20M & close above $10.50. Risk: analyst targets are not guarantees. #RiskFirst #NYSE

Just got done gutting a deer it was a huge 12 point buck!